What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects

What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects

What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects


Attachment: IIR Chart - Pharma-Biotech Project Completed in 1Q12

Pharma-Biotech Projects Completed in 1Q12SUGAR LAND--March 27, 2012--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Theories abound regarding the Pharmaceutical-Biotech Industry, and the only fact that has emerged is it has changed and continues to do so. No construction, abundant construction, consolidation, expansion; oddly enough, all apply to this industry in transition. Sometimes, it helps to only deal with concrete facts, as in the construction concrete poured to build the 71 projects that wrapped up construction during the first quarter in North America.

Other companies featured: Cubist Pharmaceuticals (NASDAQ:CBST), Grifols USA (NASDAQ:GRFS)

Subscribe Now!(All Fields Required)

Standard Membership - Free